Approval for the xience prime and xience prime ll everolimus eluting coronary stent system. this device is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (length <= 32 mm) with reference vessel diameters of >= 2.25 mm to <= 4.25 mm.